Renato Tamaro Sells 5,036 Shares of STERIS (NYSE:STE) Stock

STERIS plc (NYSE:STE) VP Renato Tamaro sold 5,036 shares of the stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the sale, the vice president owned 5,695 shares of the company’s stock, valued at approximately $1,466,747.25. This represents a 46.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

STERIS Stock Performance

Shares of STERIS stock traded up $2.38 during trading hours on Thursday, hitting $257.09. 623,583 shares of the company’s stock traded hands, compared to its average volume of 604,437. The company has a fifty day simple moving average of $246.54 and a 200-day simple moving average of $241.03. STERIS plc has a 12-month low of $200.98 and a 12-month high of $268.30. The stock has a market capitalization of $25.23 billion, a price-to-earnings ratio of 39.37 and a beta of 1.02. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the prior year, the firm posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Equities research analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Tuesday, November 18th will be issued a $0.63 dividend. The ex-dividend date of this dividend is Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS’s dividend payout ratio is presently 36.21%.

Hedge Funds Weigh In On STERIS

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Steigerwald Gordon & Koch Inc. acquired a new position in STERIS in the third quarter valued at $25,000. Spurstone Advisory Services LLC bought a new stake in STERIS in the second quarter valued at $29,000. Cloud Capital Management LLC bought a new stake in shares of STERIS during the third quarter valued at approximately $29,000. Geneos Wealth Management Inc. raised its holdings in shares of STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 104 shares in the last quarter. Finally, Zions Bancorporation National Association UT acquired a new position in shares of STERIS in the 1st quarter valued at $37,000. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on STE shares. Morgan Stanley lifted their price target on shares of STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research note on Friday, August 8th. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Tuesday, October 14th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, STERIS currently has a consensus rating of “Moderate Buy” and an average price target of $273.50.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.